Press releases & news

 

2018-10-23

News

Poster presentation at ESMO 2018 in Munich

2cureX AB (“2cureX”) hereby announces that one of its clinical partners, Vejle Hospital presented a poster at the ESMO (European...

2018-10-19

News

2cureX CEO-Interview Ole Thastrup CE-IVD status IndiTreat® and 2cureX commercial outlook

Last week, 2cureX took a big step towards market launch of IndiTreat by obtaining CE-IVD labelling of the product. Below,...

2018-10-18

News

Article from BioStock

BioStock article about CE-IVD certification. The article is in Swedish. Read it here

2018-10-15

News

2cureX presented on Sedermera Day, 11th October in Gothenburg

CEO Ole Thastrup and CBO Maarten van der Linden presented 2cureX, including the Breaking News that 2cureX has obtained CE-IVD...

2018-10-03

News

Supplementary information concerning the newsletter ”2cureX German subsidiary receives contribution for the development of IndiTreat® tests in immuno-oncology”

2cureX AB published on 2018-10-03 a corporate news that the company’s German subsidiary 2cureX GmbH (”2cureX”) had received a grant...

2018-10-03

News

2cureX German subsidiary receives contribution for the development of IndiTreat® tests in immuno-oncology

2cureX AB’s German subsidiary 2cureX GmbH (“2cureX”) has received funding from the German Federal Ministry of Education and Research to...

« Older news
More recent news »

Contact information

Laboratory: 2cureX, Fruebjergvej 3, 2100 Copenhagen Ø, Denmark| Phone: +45 2211 5399| E-mail: info@2curex.com

Privacy Policy | Imprint